Clinical Trials
Closed
Phase
Accrual
32%
Published
SWOG Clinical Trial Number
SWOG-9427
Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
03-01-1997
Closed
06-01-2000
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
S9627
Hydroxyurea, Etoposide (VP-16) and Dacarbazine (DTIC) [HED] for Patients with Unresectable or Metastatic GI Stromal Tumors, Phase II
Research Committee(s)
Sarcoma
Activated
03-01-1997
Closed
03-01-1999
Closed
Phase
Accrual
43%
Published
SWOG Clinical Trial Number
SWOG-9342
A Study of the Late Cardiac Effects of Two Different Adjuvant Chemotherapy Regimens in Women With Node Negative Breast Cancer Treated on SWOG-8897
Research Committee(s)
Breast Cancer
Activated
02-15-1997
Closed
11-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9511
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach
Activated
01-15-1997
Closed
11-15-1998
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S9622
Evaluation of CI-980 in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II
Research Committee(s)
Melanoma
Activated
12-15-1996
Closed
08-01-1998
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
SWOG-9430
A Phase II Trial of Complete Surgical Resection for Stage IV Melanoma-Surgical Resection with Biological and Clinical Follow-Up
Research Committee(s)
Melanoma
Activated
11-15-1996
Closed
11-15-2005
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9431
Cytogenetic, Molecular and Cellular Biology Studies in Metastatic Melanoma Patients, Ancillary
Research Committee(s)
Melanoma
Activated
11-15-1996
Closed
12-15-2005
Closed
Phase
Accrual
8%
SWOG Clinical Trial Number
SWOG-9455
A Phase II Study of 5-FU Infusion and Alpha Interferon for Treatment of Advanced or Recurrent Metastatic Adenocarcinoma of the Bladder
Research Committee(s)
Genitourinary Cancer
Activated
11-15-1996
Closed
12-01-1998
Closed
Phase
Accrual
93%
Published
SWOG Clinical Trial Number
S9628
Phase II Study of Dexamethasone/Alpha Interferon In AL Amyloidosis
Research Committee(s)
Myeloma
Activated
11-01-1996
Closed
03-15-2003
Closed
Phase
Accrual
78%
Published
SWOG Clinical Trial Number
SWOG-9510
Evaluation of Topotecan in Hormone Refractory Prostate Cancer, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
11-01-1996
Closed
08-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9617
A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML).
Research Committee(s)
Leukemia
Activated
11-01-1996
Closed
09-01-1998
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S9615
Neoadjuvant Hormonal Therapy Prior to Radical Prostatectomy for T1 - 2 Adenocarcinoma of the Prostate, Phase III
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1996
Closed
07-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9504
A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-1996
Closed
12-01-1998
Closed
Phase
Accrual
96%
Published
SWOG Clinical Trial Number
S9618
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9457
Paclitaxel (Taxol®) and Carboplatin for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
07-15-1996
Closed
04-15-2000
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S9623
A Comparison of Intensive Sequential Chemotherapy using Doxorubicin plus Paclitaxel plus Cyclophosphamide with High Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Support for Primary Breast Cancer in Women with >= 4 Involved Axillary Lymph Nodes, Phase III, Intergroup.
Research Committee(s)
Breast Cancer
Activated
07-01-1996
Closed
02-15-2001
Closed
Phase
Accrual
68%
Published
SWOG Clinical Trial Number
SWOG-9519
Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Research Committee(s)
Head and Neck Cancer
Activated
06-15-1996
Closed
11-01-1997
Closed
Phase
Accrual
34%
Published
SWOG Clinical Trial Number
SWOG-9460
Phase IIb Randomized Chemoprevention Trial of N-(4-Hydroxyphenyl) Retinamide (4-HPR) in Transitional Cell Bladder Carcinoma
Activated
06-01-1996
Closed
10-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9619
Closed
Phase
Accrual
87%
Published
SWOG Clinical Trial Number
SWOG-9451
Induction Chemotherapy Followed by Chemoradiation for Organ Preservation in Patients with Advanced Resectable Cancer of the Hypopharynx and Base of Tongue, Phase II
Research Committee(s)
Head and Neck Cancer
Activated
04-12-1996
Closed
12-01-2001